158 related articles for article (PubMed ID: 32422139)
1. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer.
Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D
Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139
[TBL] [Abstract][Full Text] [Related]
2. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
Liu H; Zhao J; Fu R; Zhu C; Fan D
PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
[TBL] [Abstract][Full Text] [Related]
3. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
4. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT.
Liang Y; Li S; Zheng G; Zhang L
Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
[TBL] [Abstract][Full Text] [Related]
6. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
7. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F
Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo.
Duan Z; Wei B; Deng J; Mi Y; Dong Y; Zhu C; Fu R; Qu L; Fan D
Biochem Biophys Res Commun; 2018 May; 499(3):482-487. PubMed ID: 29596831
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway.
Jiao L; Wang S; Zheng Y; Wang N; Yang B; Wang D; Yang D; Mei W; Zhao Z; Wang Z
Biochem Pharmacol; 2019 Mar; 161():149-162. PubMed ID: 30684465
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells.
Wu Q; Deng J; Fan D; Duan Z; Zhu C; Fu R; Wang S
Biochem Pharmacol; 2018 Feb; 148():64-74. PubMed ID: 29225132
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway.
Chen J; Duan Z; Liu Y; Fu R; Zhu C
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893895
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway.
Zhang W; Bhagwath AS; Ramzan Z; Williams TA; Subramaniyan I; Edpuganti V; Kallem RR; Dunbar KB; Ding P; Gong K; Geurkink SA; Beg MS; Kim J; Zhang Q; Habib AA; Choi SH; Lapsiwala R; Bhagwath G; Dowell JE; Melton SD; Jie C; Putnam WC; Pham TH; Wang DH
Mol Cancer Ther; 2021 Oct; 20(10):1904-1915. PubMed ID: 34376577
[TBL] [Abstract][Full Text] [Related]
14. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA
Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis.
Dong F; Qu L; Duan Z; He Y; Ma X; Fan D
Bioorg Chem; 2023 Jun; 135():106537. PubMed ID: 37043883
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
18. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
[TBL] [Abstract][Full Text] [Related]
19. Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes.
Jia L; Gao Y; Zhou T; Zhao XL; Hu HY; Chen DW; Qiao MX
Biomaterials; 2021 Apr; 271():120711. PubMed ID: 33592352
[TBL] [Abstract][Full Text] [Related]
20. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
